Dr Rejman commented in his written statement that his understanding was that national implementation of Hepatitis C screening should be coordinated to avoid possible medico-legal complications in the future, which was a common view. Linked evidence WITN4486040 - Third Written Statement of Dr Andrzej Rejman; 27 Apr 2022 Chronology Information Date: 27 April 2022 Chapter/issue Hepatitis C Screening Key Person(s) Dr Andrzej Rejman
Dr Rejman commented in his written statement that his understanding was that national implementation of Hepatitis C screening should be coordinated to avoid possible medico-legal complications in the future, which was a common view.
Chronology Information
Date:
Documents
WITN4486040 Third Written Statement of Dr Andrzej Rejman 27 Apr 2022